SOM230 s.c. ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
75クッシング病1

75. クッシング病


臨床試験数 : 205 薬物数 : 176 - (DrugBank : 45) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 127
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00088608
(ClinicalTrials.gov)
April 200430/7/2004A Study to Assess SOM230 in Patients With Pituitary Cushing's DiseaseA Multicenter, Open Label Study to Assess the Safety and Efficacy of 600 µg SOM230, Administered Subcutaneously, b.i.d. in Patients With Cushing's DiseaseCushing's SyndromeDrug: SOM230 s.c.Novartis PharmaceuticalsNULLCompleted18 Years80 YearsBoth26Phase 2United States;France;Italy;United Kingdom